Eliquis and Hypercholesterolaemia aggravated - a phase IV clinical study of FDA data
Summary:
Hypercholesterolaemia aggravated is reported as a side effect among people who take Eliquis (apixaban), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have High blood pressure.
The phase IV clinical study analyzes which people have Hypercholesterolaemia aggravated when taking Eliquis. It is created by eHealthMe based on reports of 189,425 people who have side effects when taking Eliquis from the FDA, and is updated regularly.
What is Eliquis?
Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,864 Eliquis users. Check the latest studies of Eliquis.
What is Hypercholesterolaemia aggravated?
Hypercholesterolaemia aggravated (high levels of cholesterol in the blood) is found to be associated with 1,527 drugs and 509 conditions by eHealthMe. Check the latest studies of Hypercholesterolaemia aggravated.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
189,425 people reported to have side effects when taking Eliquis.
Among them, 404 people (0.21%) have Hypercholesterolaemia aggravated.
Among these 404 people:
How long have people been on Eliquis when they have Hypercholesterolaemia aggravated? *
What is the gender of people who have Hypercholesterolaemia aggravated when taking Eliquis? *
What is the age of people who have Hypercholesterolaemia aggravated when taking Eliquis? *
What are other drugs people take besides Eliquis? *
What are other side effects people have besides Hypercholesterolaemia aggravated? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Eliquis and have Hypercholesterolaemia aggravated?
- Check whether Hypercholesterolaemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Eliquis:
- Eliquis (191,864 reports)
Hypercholesterolaemia aggravated treatments and more:
- Hypercholesterolaemia aggravated (43 reports)
How severe was Hypercholesterolaemia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of apixaban:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Eliquis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hypercholesterolaemia aggravated:
- Hypercholesterolaemia aggravated (1,527 drugs)
Browse all the conditions that are associated with Hypercholesterolaemia aggravated:
- Hypercholesterolaemia aggravated (509 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on apixaban (the active ingredients of Eliquis) and Eliquis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cognex cause Weakness? - a second ago
- Could Bosentan cause Arthritis? - 6 seconds ago
- Could Beconase cause Pain Exacerbated? - 8 seconds ago
- Could Elavil cause Headache? - 11 seconds ago
- Could Colace cause Birth Control? - 13 seconds ago
- Drug interactions of Xyrem and D-Ribose - 13 seconds ago
- Could Tazorac cause Intestinal Obstruction? - 13 seconds ago
- Could Elavil cause Osteopenia? - 14 seconds ago
- Could Orphenadrine Citrate cause Peripheral Swelling? - 18 seconds ago
- Could Taltz cause Paraesthesia? - 19 seconds ago